{"title":"新冠肺炎大流行时代临床试验的制度变迁","authors":"T. Miyaji, T. Kiuchi, Takuhiro Yamaguchi","doi":"10.47912/jscdm.103","DOIUrl":null,"url":null,"abstract":"To understand the current phenomena of conducting clinical trials in the era of the coronavirus disease (COVID-19) and prepare for a change in conduct, it might be worth to understand the phenomena of clinical trials from the perspective of “institutional change”. This short perspective paper will describe the basic concepts of institutions and institutional change and explore expected institutional changes in clinical trials as a result of the coronavirus disease (COVID-19).","PeriodicalId":440423,"journal":{"name":"Journal of the Society for Clinical Data Management","volume":"46 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Institutional Change in Clinical Trials in the era of the COVID-19 Pandemic\",\"authors\":\"T. Miyaji, T. Kiuchi, Takuhiro Yamaguchi\",\"doi\":\"10.47912/jscdm.103\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To understand the current phenomena of conducting clinical trials in the era of the coronavirus disease (COVID-19) and prepare for a change in conduct, it might be worth to understand the phenomena of clinical trials from the perspective of “institutional change”. This short perspective paper will describe the basic concepts of institutions and institutional change and explore expected institutional changes in clinical trials as a result of the coronavirus disease (COVID-19).\",\"PeriodicalId\":440423,\"journal\":{\"name\":\"Journal of the Society for Clinical Data Management\",\"volume\":\"46 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the Society for Clinical Data Management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47912/jscdm.103\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Society for Clinical Data Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47912/jscdm.103","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Institutional Change in Clinical Trials in the era of the COVID-19 Pandemic
To understand the current phenomena of conducting clinical trials in the era of the coronavirus disease (COVID-19) and prepare for a change in conduct, it might be worth to understand the phenomena of clinical trials from the perspective of “institutional change”. This short perspective paper will describe the basic concepts of institutions and institutional change and explore expected institutional changes in clinical trials as a result of the coronavirus disease (COVID-19).
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
